Bullish Moving Averages
5
Bearish Moving Averages
11
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
1201.00Today’s High
1222.4052W low
825.0052W High
1474.40Open Price
1201.00Prev. Close
1201.5500Volume
15100.00Value
18181155.00Fundamentals
Market Cap
2361.30
Price to Earnings
-30.10
Price to Book Value
6.40
Dividend Yield
0.00
PE to Growth
0.00
Op Revenue TTM
384.70
Net Profit TTM
-78.46
Cash From Operating Activity
10.22
Return on Equity %
-12.70
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
12 Sep, 2024
80.8
Week
68.3
Month
59.2
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
1205.78
PIVOT
First Resistance
1211.52
Second Resistance
1218.28
Third Resistance
1224.02
First Support
1199.02
Second Support
1193.28
Third Support
1186.52
Relative Strength Index
46.63
Money Flow Index
49.49
MACD
-9.31
MACD Signal
-11.42
Average True Range
34.17
Average Directional Index
11.09
Rate of Change (21)
-1.6
Rate of Change (125)
13.77
Day Commodity Channel Index
-6.5
Day Williams %R
-67.4
BETA
1 Month
0.47
3 Month
1.15
1 Year
0.45
3 Year
0.15
PRICE CHANGE ANALYSIS
↓ -0.24%
1 Week
Low
High
1185
1234.95
↓ -4.74%
1 Month
Low
High
1130.1
1262.4
↓ 0.04%
3 Months
Low
High
1130.1
1474.4
↑ 18.12%
6 Months
Low
High
1005.05
1474.4
↓ -12.21%
1 Year
Low
High
825.05
1474.4
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 70.28 | 155.78 | 51.69 | 111.74 | 144.55 | 129.54 | 120.96 | 203.73 | 186.97 | 278.78 | 175.31 | 103.47 | 129.46 | |
| Operating Expenses Qtr | 115.62 | 141.04 | 69.12 | 114.21 | 139.71 | 121.57 | 105.05 | 166.47 | 158.81 | 206.52 | 130.49 | 81.49 | 103.98 | |
| Operating Profit Qtr | -46.25 | 12.71 | -18.33 | -3.42 | 3.14 | 5.40 | 12.13 | 33.28 | 25.45 | 65.46 | 42.86 | 21.08 | 24.67 | |
| EBIDT Qtr Cr | -45.34 | 14.74 | -17.43 | -2.46 | 4.83 | 7.97 | 15.91 | 37.26 | 28.16 | 72.26 | 44.82 | 21.98 | 25.48 | |
| Depreciation Qtr | 9.28 | 9.02 | 8.72 | 9.17 | 9.40 | 7.77 | 8.81 | 8.18 | 8.94 | 10.66 | 9.07 | 8.17 | 6.52 | |
| Net Profit Qtr | -39.74 | -0.99 | -24.35 | -13.45 | -8.21 | -5.00 | 0.83 | 18.30 | 11.39 | 43.04 | 24.74 | 9.06 | 12.97 | |
| Basic EPS Qtr | -20.26 | -0.50 | -12.42 | -6.86 | -4.19 | -2.55 | 0.42 | 9.34 | 5.81 | 21.97 | 12.63 | 4.63 | 6.62 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 463.76 | 641.20 | 687.03 | 562.54 | 534.15 | |
| Operating Expenses Annual Cr | 464.08 | 551.90 | 522.48 | 443.37 | 437.02 | |
| Operating Profit Annual | -5.90 | 76.27 | 154.08 | 111.51 | 85.20 | |
| Operating Profit Margin Annual % | -1.27 | 11.89 | 22.43 | 19.82 | 15.95 | |
| Total Expenses Annual Cr | 525.64 | 606.35 | 565.99 | 473.87 | 472.88 | |
| EBIDT Annual Cr | -0.32 | 89.30 | 164.55 | 119.18 | 97.14 | |
| EBIDT Annual margin % | -0.07 | 13.93 | 23.95 | 21.19 | 18.19 | |
| Depreciation | 36.31 | 33.71 | 34.42 | 25.71 | 23.22 | |
| PAT Before ExtraOrdinary Items Annual Cr | -46.99 | 25.52 | 89.82 | 64.69 | 47.47 | |
| Net Profit Annual | -46.99 | 25.52 | 89.82 | 64.69 | 47.47 | |
| Basic EPS Annual | -23.96 | 13.02 | 45.85 | 33.05 | 24.27 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 368.68 | 418.79 | 395.98 | 308.70 | 246.44 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 208.22 | 33.73 | 9.75 | 46.23 | 6.78 | |
| Total Current Liabilities Annual Cr | 397.25 | 526.33 | 490.98 | 322.97 | 318.88 | |
| Total Capital Plus Liabilities Annual Cr | 974.15 | 978.85 | 896.71 | 677.90 | 572.10 | |
| Fixed Assets Annual | 550.82 | 444.95 | 362.71 | 328.38 | 217.79 | |
| Total Non Current Assets Annual | 576.67 | 480.75 | 378.90 | 347.47 | 240.41 | |
| Total Current Assets Annual | 397.48 | 498.09 | 517.81 | 330.43 | 331.69 | |
| Total Assets Annual | 974.15 | 978.85 | 896.71 | 677.90 | 572.10 | |
| Contingent Liabilities plus Commitments Annual Cr | 213.77 | 256.13 | 215.22 | 233.72 | 209.82 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 10.13 | 74.32 | 23.41 | -8.06 | 168.56 | |
| Cash from Investing Activity Annual | -134.98 | -112.07 | -103.57 | -73.11 | -73.81 | |
| Cash from Financing Annual Activity | 124.85 | 37.66 | 80.37 | 81.23 | -94.64 | |
| Net Cash Flow Annual | 0.00 | -0.09 | 0.22 | 0.06 | 0.11 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 188.01 | 213.61 | 202.06 | 157.60 | 125.94 | |
| ROE Annual % | -12.74 | 6.09 | 22.68 | 20.95 | 19.26 | |
| ROCE Annual % | -6.34 | 12.28 | 32.07 | 26.33 | 29.18 | |
| Total Debt to Total Equity Annual | 1.34 | 0.81 | 0.71 | 0.61 | 0.40 | |
| EBDIT Annual Margin % | -0.06 | 14.21 | 24.32 | 21.47 | 18.60 |
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 70.30 | 155.80 | 51.70 | 111.77 | 144.56 | 129.55 | 120.97 | 203.73 | 186.98 | 278.79 | 175.31 | 103.47 | 129.46 | |
| Operating Expenses Qtr | 115.63 | 141.04 | 69.13 | 114.21 | 139.72 | 121.57 | 105.06 | 166.47 | 158.82 | 206.52 | 130.49 | 81.49 | 103.99 | |
| Operating Profit Qtr | -46.26 | 12.71 | -18.33 | -3.42 | 3.13 | 5.40 | 12.12 | 33.28 | 25.45 | 65.46 | 42.86 | 21.08 | 24.67 | |
| EBIDT Qtr Cr | -45.33 | 14.76 | -17.42 | -2.44 | 4.84 | 7.98 | 15.91 | 37.26 | 28.16 | 72.27 | 44.82 | 21.98 | 25.47 | |
| Depreciation Qtr | 9.27 | 9.01 | 8.70 | 9.16 | 9.39 | 7.76 | 8.80 | 8.17 | 8.93 | 10.64 | 9.06 | 8.15 | 6.51 | |
| Net Profit Qtr | -39.72 | -0.97 | -24.33 | -13.43 | -8.19 | -4.98 | 0.84 | 18.31 | 11.40 | 43.05 | 24.75 | 9.08 | 12.98 | |
| Basic EPS Qtr | -20.26 | -0.50 | -12.41 | -6.85 | -4.18 | -2.54 | 0.43 | 9.34 | 5.82 | 21.97 | 12.63 | 4.63 | 6.63 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 463.82 | 641.23 | 687.03 | 562.79 | 534.54 | |
| Operating Expenses Annual Cr | 464.09 | 551.91 | 522.49 | 443.32 | 437.43 | |
| Operating Profit Annual | -5.91 | 76.25 | 154.07 | 111.56 | 85.18 | |
| Operating Profit Margin Annual % | -1.27 | 11.89 | 22.43 | 19.82 | 15.93 | |
| Total Expenses Annual Cr | 525.57 | 606.28 | 565.91 | 473.72 | 473.19 | |
| EBIDT Annual Cr | -0.27 | 89.31 | 164.54 | 119.48 | 97.11 | |
| EBIDT Annual margin % | -0.06 | 13.93 | 23.95 | 21.23 | 18.17 | |
| Depreciation | 36.25 | 33.65 | 34.36 | 25.66 | 23.16 | |
| PAT Before ExtraOrdinary Items Annual Cr | -46.89 | 25.59 | 89.88 | 65.07 | 47.53 | |
| Net Profit Annual | -46.93 | 25.56 | 89.86 | 65.05 | 47.51 | |
| Basic EPS Annual | -23.93 | 13.04 | 45.85 | 33.21 | 24.27 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 369.29 | 419.36 | 396.50 | 309.18 | 246.57 | |
| Minority Interest Liability Annual Cr | 0.23 | 0.19 | 0.16 | 0.14 | 0.33 | |
| Total Non Current Liabilities Annual Cr | 208.25 | 33.66 | 9.51 | 45.99 | 6.46 | |
| Total Current Liabilities Annual Cr | 397.16 | 526.20 | 490.59 | 322.28 | 318.36 | |
| Total Capital Plus Liabilities Annual Cr | 974.93 | 979.41 | 896.76 | 677.59 | 571.72 | |
| Fixed Assets Annual | 551.00 | 445.08 | 362.77 | 328.39 | 217.73 | |
| Total Non Current Assets Annual | 576.44 | 480.56 | 381.08 | 347.16 | 239.97 | |
| Total Current Assets Annual | 398.49 | 498.85 | 515.68 | 330.43 | 331.75 | |
| Total Assets Annual | 974.93 | 979.41 | 896.76 | 677.59 | 571.72 | |
| Contingent Liabilities plus Commitments Annual Cr | 213.66 | 256.17 | 239.82 | 233.75 | 274.87 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 10.22 | 74.66 | 23.60 | -8.16 | 168.44 | |
| Cash from Investing Activity Annual | -135.18 | -112.51 | -103.87 | -73.11 | -73.81 | |
| Cash from Financing Annual Activity | 124.96 | 37.77 | 80.48 | 81.34 | -94.53 | |
| Net Cash Flow Annual | -0.00 | -0.08 | 0.22 | 0.06 | 0.10 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 188.44 | 214.00 | 202.40 | 157.91 | 126.17 | |
| ROE Annual % | -12.70 | 6.09 | 22.66 | 21.03 | 19.26 | |
| ROCE Annual % | -6.32 | 12.28 | 32.05 | 26.40 | 29.18 | |
| Total Debt to Total Equity Annual | 1.34 | 0.81 | 0.70 | 0.60 | 0.40 | |
| EBDIT Annual Margin % | -0.05 | 14.21 | 24.31 | 21.53 | 18.58 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| ASHOK VISHWANATH HIREMATH | 1.99 | 88982091 | 0 | 0 |
| GODREJ AGROVET LIMITED | 64.76 | 88982094 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA SMALL CAP FUND | 2.39 | 88982097 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| SHREANS DAGA | 1.9 | 88982108 |
| KAUSHIK DAGA | 1.67 | 88982109 |
| HUF | 1.54 | 88982102 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Jul 21, 2023 | 1.5 | FINAL | - | Equity Share |
| Jul 19, 2022 | 1.5 | FINAL | - | Equity Share |
| Jul 22, 2021 | 1.5 | FINAL | - | Equity Share |
| Jul 16, 2020 | 1.5 | FINAL | - | Equity Share |
| Jul 18, 2019 | 1.5 | FINAL | - | Equity Share |
| Jul 19, 2018 | 1.5 | FINAL | - | Equity Share |
| Jul 17, 2017 | 1.5 | FINAL | - | Equity Share |
| Sep 15, 2015 | 1.25 | FINAL | - | Equity Share |
| Sep 15, 2014 | 1 | FINAL | - | Equity Share |
| Sep 02, 2013 | 0.75 | FINAL | - | Equity Share |
| Sep 13, 2012 | 0.5 | FINAL | - | Equity Share |
| Sep 15, 2011 | 0.5 | FINAL | - | Equity Share |
| Aug 12, 2010 | 1 | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| Jul 29, 2024 | Quarterly Results | - |
| May 02, 2024 | Audited Results | - |
| Jan 25, 2024 | Quarterly Results | - |
| Oct 27, 2023 | Quarterly Results & Others | - |
| Jul 27, 2023 | Quarterly Results | - |
| May 02, 2023 | Audited Results & Final Dividend | - |
| Jan 30, 2023 | Quarterly Results & Others | Inter alia, the Board may also consider and approve issuance of Debentures or debt securities upto such limit as may be deemed appropriate and approved by the Board. |
| Oct 28, 2022 | Quarterly Results | - |
| Jul 25, 2022 | Quarterly Results | - |
| May 02, 2022 | Audited Results & Final Dividend | - |
| Jan 25, 2022 | Quarterly Results | - |
| Oct 27, 2021 | Quarterly Results | - |
| Jul 28, 2021 | Quarterly Results | - |
| Apr 30, 2021 | Audited Results & Final Dividend | - |
| Jan 25, 2021 | Quarterly Results | - |
| Oct 29, 2020 | Quarterly Results | - |
| Jul 22, 2020 | Quarterly Results | - |
| May 05, 2020 | Audited Results & Final Dividend | - |
| Jan 30, 2020 | Quarterly Results | - |
| Oct 25, 2019 | Quarterly Results | - |
| Jul 26, 2019 | Quarterly Results | - |
| Apr 30, 2019 | Audited Results & Final Dividend | - |
| Jan 25, 2019 | Quarterly Results | - |
| Oct 26, 2018 | Quarterly Results | - |
| Sep 14, 2018 | Amalgamation | inter alia, to consider and approve Scheme of Amalgamation of the Company with Godrej Agrovet Limited (Holding Company). |
| Aug 01, 2018 | Quarterly Results | - |
| May 02, 2018 | Audited Results & Final Dividend | - |
| Jan 31, 2018 | Quarterly Results | - |
| Oct 25, 2017 | Quarterly Results | - |
| Jul 28, 2017 | Quarterly Results | - |
| May 04, 2017 | Audited Results & Final Dividend | - |
| Mar 25, 2017 | Others | Allotted 9,000 (Nine Thousand) Equity Shares of Face Value Rs.10/- each to the employees of the Company upon exercise of 9,000 (Nine Thousand) Options granted to them, at an exercise price of Rs.34/- |
| Jan 25, 2017 | Quarterly Results | - |
| Oct 27, 2016 | Quarterly Results | - |
| Jul 26, 2016 | Quarterly Results | Allotted 21,200 (Twenty One Thousand Two Hundred) Equity Shares of Face Value Rs.10/- each to the employees of the Company on exercise of Options granted to them, at an exercise price of Rs. 34/-. |
| May 04, 2016 | Audited Results | - |
| Jan 29, 2016 | Quarterly Results | 1. Appointment of Mr. Vijay Kashinath Khot as an Additional Independent Director of the Company with immediate effect; 2. Appointment of Dr. Brahma Nand Vyas as an Additional Independent Director. |
| Nov 06, 2015 | Quarterly Results | 1. Appointment Mr. N. B. Godrej as the Chairman of the Company. 2. Appointment of Mr. S. Varadaraj as an Additional Director of the Company. |
| Oct 12, 2015 | Others | Appointment of Mr. N. B. Godrej as Additional Director of the Company with immediate effect. |
| Jul 25, 2015 | Quarterly Results | - |
| May 16, 2015 | Audited Results & Dividend | - |
| Mar 05, 2015 | Re-appointment of Managing Director | Re-appointment of Mr. Janak Rawal as Whole Time Director subject to the approval of members. |
| Jan 31, 2015 | Qtrly Results & Allotment of Equity Shares | To consider allotment of 9,25,925 Equity Shares of Rs. 10/- each fully paid-up at Rs. 108/- per share (including a premium of Rs. 98/- per share) on preferential basis. |
| Dec 19, 2014 | To Consider Allotment of Equity Shares | To consider and approve the issue and allotment of Equity shares on Preferential basis of Rs.10,00,00,000/- (Rupees Ten Crores Only) including premium thereon, |
| Oct 18, 2014 | Quarterly Results | - |
| Aug 09, 2014 | Quarterly Results & Others | To alter Memorandum and Articles of Association of Company to give effect to item to increase the Authorised Capital of the Company. |
| May 30, 2014 | Audited Results & Dividend, Others | 1. Increase in Authorised Capital . 2. To alter Memorandum and Articles of Association of Company to give effect to item no. 3 & 4 above. Revised from 14/05/2014. |
| Jan 24, 2014 | Quarterly Results | - |
| Oct 23, 2013 | Quarterly Results | - |
| Sep 19, 2013 | Allotment of Equity Shares | For approving the Allotment of Equity Shares pursuant to the Conversion of Preferential Warrants convertible into Equity Shares. |
| Aug 12, 2013 | Quarterly Results | - |
| May 24, 2013 | Audited Results & Dividend | - |
| Feb 14, 2013 | Quarterly Results | - |
| Jan 04, 2013 | Conversion of Preferential Warrants | To Consider the Allotment of Equity Shares pursuant to the Conversion of Preferential Warrants convertible into Equity Shares. |
| Nov 12, 2012 | Quarterly Results | - |
| Aug 09, 2012 | Quarterly Results | - |
| May 28, 2012 | Audited Results, Dividend & Others | To appoint Non-Executive & Independent Director. |
| Feb 29, 2012 | Increase in Authorised Capital & Others | To increase Authorized Capital of the Company from Rs. 17,00,00,OOO/- to Rs. 20,00,00,OOO/- & to issuance of 16,00,000 Convertible Warrants into Equity Shares on preferential basis. |
| Feb 14, 2012 | Quarterly Results | - |
| Jan 04, 2012 | Appointment of Whole Time Director | To consider the followings: 1. Appointment of Mr. Janak Rawal as Whole Time Director, subject to the approval of members. 2. Re-appointment of Mr. Ashok V Hiremath as Chairman & Managing Director. |
| Nov 12, 2011 | Quarterly Results | - |
| Aug 10, 2011 | Quarterly Results | - |
| May 27, 2011 | Audited Results & Dividend | - |
| Feb 05, 2011 | Quarterly Results | - |
| Nov 10, 2010 | Quarterly Results | - |
| Aug 05, 2010 | Quarterly Results | - |
| May 24, 2010 | Audited Results & Dividend | - |
| Jan 28, 2010 | Quarterly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
04 Sep 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Kindly find enclosed the intimation of allotment of ESOP.
04 Sep 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Intimation Of Appointment Of Senior Management Personnel
Kindly find enclosed the intimation for appointment of Senior Management Personnel.
21 Aug 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Change In Senior Management Personnel
Kindly find enclosed the change in Senior Management Personnel.
07 Aug 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Credit Rating
Kindly find enclosed the re-affirmed credit rating of the Company.
01 Aug 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Draft Letter of Offer
Kotak Mahindra Capital Company Ltd ("Manager to the Offer") has submitted to BSE a copy of Draft Letter of Offer to the public shareholders of Astec Lifesciences Ltd ("Target Company").
01 Aug 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Godrej Agrovet Ltd
30 Jul 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Voting Results Of The 30Th (Thirtieth) Annual General Meeting
Kindly find enclosed the voting results for the 30th AGM.
30 Jul 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Kindly find enclosed the newspaper publication for the Quarter ended June 30, 2024.
30 Jul 2024
Q1FY25 Quarterly Result Announced for Astec Lifesciences Ltd.
Agrochemicals company Astec Lifesciences announced Q1FY25 results: Financial Highlights: Company reported consolidated total income of Rs 70.3 crore in Q1FY25 as compared to Rs 144.6 crore in Q1FY24 Company reported consolidated EBITDA loss of Rs 45.3 crore in Q1FY25 as compared to profit of Rs 4.8 crore in the same period last year Commenting on the performance, N B Godrej, Chairman, Astec LifeSciences, said: Astec continued to face pricing and demand headwinds in the enterprise products on account of destocking of the inventory across key markets. Challenging external environment necessitated write down of inventory which also significantly impacted the margins of the enterprise portfolio. Also, global logistics issues resulted in delay in receipt of essential raw materials for our Contract Manufacturing (CDMO) product which resulted in deferral of volumes. This unfortunate situation further compressed overall profit margins. Result PDF
29 Jul 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Kindly find enclosed the Scrutinizer''s Report for the Annual General Meeting held on Monday, 29 July, 2024.
